Cargando…
Physiologically based pharmacokinetic modeling for dose optimization of quinine–phenobarbital coadministration in patients with cerebral malaria
Patients with cerebral malaria with polymorphic Cytochrome P450 2C19 (CYP2C19) genotypes who receive concurrent treatment with quinine are at risk of inadequate or toxic therapeutic drug concentrations due to metabolic drug interactions. The study aimed to predict the potential dose regimens of quin...
Autores principales: | Sae‐heng, Teerachat, Rajoli, Rajith Kumar Reddy, Siccardi, Marco, Karbwang, Juntra, Na‐Bangchang, Kesara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752110/ https://www.ncbi.nlm.nih.gov/pubmed/34730282 http://dx.doi.org/10.1002/psp4.12737 |
Ejemplares similares
-
Clinical pharmacokinetics of quinine and its relationship with treatment outcomes in children, pregnant women, and elderly patients, with uncomplicated and complicated malaria: a systematic review
por: Saeheng, Teerachat, et al.
Publicado: (2022) -
Pharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malaria
por: Na-Bangchang, Kesara, et al.
Publicado: (2007) -
β-Eudesmol induces the expression of apoptosis pathway proteins in cholangiocarcinoma cell lines
por: Narahara, Chisato, et al.
Publicado: (2020) -
Traditional Herbal Medicine for the Control of Tropical Diseases
por: Na-Bangchang, Kesara, et al.
Publicado: (2014) -
Research and Development of Atractylodes lancea (Thunb) DC. as a Promising Candidate for Cholangiocarcinoma Chemotherapeutics
por: Na-Bangchang, Kesara, et al.
Publicado: (2017)